Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 90/100

Failure Rate

28.6%

2 terminated/withdrawn out of 7 trials

Success Rate

50.0%

-36.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

1 with results

Enrollment Performance

Analytics

N/A
4(100.0%)
4Total
N/A(4)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials
NCT03958539Not ApplicableTerminated

Prevention of Primary Foot Ulcers in High-risk Diabetes Patients

Role: collaborator

NCT05901142Not ApplicableActive Not Recruiting

Prehabilitation and RecOVERy From Surgery for Breast Cancer Study

Role: collaborator

NCT04805216Completed

Covid-19 Vaccine Response in Immunocompromised Haematology Patients

Role: collaborator

NCT03089463Suspended

Foot Assessment in People With Diabetes: A Quantitative Diagnostic Approach

Role: lead

NCT04630795Unknown

ViscoTurf - Preventing Secondary Diabetic Foot Ulceration.

Role: lead

NCT04469374Not ApplicableTerminated

Menopause Osteoporosis and Bone Intervention Using Lifestyle Exercise.

Role: lead

NCT01816906Not ApplicableCompleted

Development and Testing of a New Generation of Diabetic Footwear

Role: lead

All 7 trials loaded